Search hospitals > Kansas > Kansas City
University of Kansas Medical Center
Claim this profileKansas City, Kansas 66103
Global Leader in Fibrosis
Global Leader in Multiple Sclerosis
Conducts research for High Blood Pressure
Conducts research for Syndrome
Conducts research for Parkinson's Disease
1261 reported clinical trials
84 medical researchers
Summary
University of Kansas Medical Center is a medical facility located in Kansas City, Kansas. This center is recognized for care of Fibrosis, Multiple Sclerosis, High Blood Pressure, Syndrome, Parkinson's Disease and other specialties. University of Kansas Medical Center is involved with conducting 1,261 clinical trials across 983 conditions. There are 84 research doctors associated with this hospital, such as Dhanunjaya Lakkireddy, Jeffrey Statland, Leslie Spikes, and Rajesh Pahwa.Area of expertise
1Fibrosis
Global LeaderCFTR positive
F508del
minimal function mutation
2Multiple Sclerosis
Global LeaderTop PIs
Dhanunjaya LakkireddyKansas City Cardiac Arrhythmia Research Foundation2 years of reported clinical research
Expert in Atrial Fibrillation
Studies Cardiac Arrhythmias
23 reported clinical trials
23 drugs studied
Jeffrey StatlandUniversity of Kansas Medical Center1 year of reported clinical research
Studies Muscular Dystrophy
Studies Duchenne Muscular Dystrophy
19 reported clinical trials
19 drugs studied
Leslie SpikesUniversity of Kansas Medical Center2 years of reported clinical research
Expert in High Blood Pressure
Expert in Pulmonary Hypertension
13 reported clinical trials
11 drugs studied
Rajesh PahwaUniversity of Kansas Medical Center3 years of reported clinical research
Expert in Parkinson's Disease
Studies Dystonia
13 reported clinical trials
12 drugs studied
Clinical Trials running at University of Kansas Medical Center
Multiple Sclerosis
Non-Small Cell Lung Cancer
Cystic Fibrosis
Pulmonary Fibrosis
Fibrosis
Syndrome
Pulmonary Arterial Hypertension
Non-Hodgkin's Lymphoma
Dementia
Multiple Myeloma
Ofatumumab
for Multiple Sclerosis
The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS).
Recruiting2 awards Phase 3
Ocrelizumab
for Multiple Sclerosis
This study will evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple sclerosis (PPMS), including participants later in their disease course. This study focuses on upper limit disability progression. This study will consist of the following phases: screening, double-blind treatment, follow-up 1 (FU1), an optional open-label extension (OLE), follow-up 2 (FU2), and B-cell monitoring (BCM).
Recruiting2 awards Phase 39 criteria
Cognitive Behavioral Therapy
for Insomnia in Multiple Sclerosis
The incidence of insomnia is estimated to be as high as 90% in individuals with MS due to insomnia being underdiagnosed. Sleep disturbances in people with MS have been associated with reduced cognitive performance, physical function, psychological well-being, quality of life, and occupational function, as well as increased prevalence of fatigue, pain, depression, and anxiety. The objective of the proposed study is to determine the efficacy of cognitive behavioral therapy for insomnia (CBT-I) to improve insomnia symptoms (Aim 1) fatigue, and health-related quality of life (Aim 2) in individuals with multiple sclerosis compared to an active control group, and to determine the characteristics of participants that predict improvement in sleep outcomes (Exploratory Aim 3).
Recruiting1 award Phase 24 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Kansas Medical Center?
University of Kansas Medical Center is a medical facility located in Kansas City, Kansas. This center is recognized for care of Fibrosis, Multiple Sclerosis, High Blood Pressure, Syndrome, Parkinson's Disease and other specialties. University of Kansas Medical Center is involved with conducting 1,261 clinical trials across 983 conditions. There are 84 research doctors associated with this hospital, such as Dhanunjaya Lakkireddy, Jeffrey Statland, Leslie Spikes, and Rajesh Pahwa.
Where is University of Kansas Medical Center located?
The University of Kansas Medical Center is located at 4000 Cambridge St, Kansas City, KS 66160-8501. Directions vary: from the North, take I-35 South from I-29 South; from the West, take I-70 East to 7th St. Trafficway South; from the East, take I-70 West to I-35 South to 7th St. Trafficway; from the South, take I-35 North to Rainbow Blvd., then south on Rainbow to 39th St. Public parking is available at Parking Garage P5.
Who should I call to ask about financial aid or insurance network?
For financial assistance at the University of Kansas Medical Center, patients without healthcare coverage can reach out to the Financial Counseling Center by calling 816-404-3000 or emailing GBC-FinancialCounselor@kumc.edu. They offer support in determining eligibility for commercial medical insurance, MO HealthNet (Medicaid), Crime Victims Compensation Fund, and the UH Financial Assistance Program, considering factors like residency, income, and family size. For insurance-related questions, please consult the contact details available on the University of Kansas Medical Center website.
What insurance does University of Kansas Medical Center accept?
The University of Kansas Medical Center accepts a wide range of insurance plans, including Blue Cross and Blue Shield, Aetna, Medicare Advantage, Medicaid, Aetna Better Health of Kansas, Home State Health Plan (MC+), and AARP/Secure Horizons Medicare Complete (UHC). Coverage extends to a variety of providers and facilities through the Blue Cross and Blue Shield network, encompassing the Kansas City metro area, greater Kansas, and nationwide. Additionally, employees of the University of Kansas Medical Center have access to medical, dental, and vision insurance, along with disability and long-term care, life insurance, and wellness programs.
What awards or recognition has University of Kansas Medical Center received?
The University of Kansas Cancer Center is recognized by the National Cancer Institute (NCI) as a "Comprehensive" cancer center, highlighting its dedication to research, education, and patient care. The University of Kansas Health System is a Magnet®-designated hospital, acknowledged for delivering superior patient care and achieving optimal outcomes. It has also been continuously accredited by The Joint Commission since 2008.